Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Variable</td><td class="align_center">OR (95% CI)</td><td class="align_center">Adjusted OR (95% CI)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Serum melatonin</td><td class="align_center">0.170 (0.069–0.423)</td><td class="align_center">0.191 (0.084–0.431)</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>Abbreviations: OR: odds ratio; CI: confidence interval for odds ratio.<br/></div></td></tr></table>

<div>The risk of cognitive impairment in T2DM patients with high serum melatonin.</div>

International Journal of Endocrinology

tab5

Table 5

Table 5: Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study 